Abstract
The title compound, C 25H 21BrN 2O 3, was synthesized and structurally characterized by elemental analysis, IR, MS, 1H NMR and single crystal X-ray diffraction. The crystal is of orthorhombic system, space group Pbca with a = 11.706(2) Å, b = 18.038(4) Å, c = 20.369(4) Å, α = 90.00°, β = 90.00°, γ = 90.00°, V = 4301.0(15) Å 3, Z = 8, Dc = 1.474 g/cm 3, F (000) = 1952.0, μ(MoKα) = 1.941 mm -1, the final R 1 = 0.0670 and wR 2 = 0.2319 for reflections with I > 2σ(I). The crystal structure is stabilized by un-classical hydrogen-bonding C-H...O forming a threedimensional network. The optimized geometric bond lengths and bond angles obtained by using density functional theory have been compared with X-ray diffraction values. In addition, the preliminary biological test showed that the title compound had anti-Mycobacterium phlei 1180 activity.
| Original language | English |
|---|---|
| Pages (from-to) | 318-322 |
| Number of pages | 5 |
| Journal | Journal of Chemical Crystallography |
| Volume | 42 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2012 |
| Externally published | Yes |
Keywords
- Biological activity
- DFT
- Synthesis
- X-ray diffraction
Fingerprint
Dive into the research topics of 'Synthesis, crystal and calculated structure, and biological activity of 2-((6-bromo-2-methoxyquinolin-3-yl) (phenyl)methyl)-2,3,7,7a-tetrahydro-3a,6- epoxyisoindol-1(6H)-one'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver